![Marc Hellerstein](/sites/default/files/styles/faculty_photo_thumbnail/public/2023-05/Marc%20Hellerstein.jpg?h=a2634f0d&itok=qfbsxJMW)
![Marc Hellerstein](/sites/default/files/styles/faculty_photo_thumbnail/public/2023-05/Marc%20Hellerstein.jpg?h=a2634f0d&itok=qfbsxJMW)
Research Expertise and Interest
plant biology, health and nutrition
In the News
For an effective COVID vaccine, look beyond antibodies to T-cells
More than 100 companies have rushed into vaccine development against COVID-19 as the U.S. government pushes for a vaccine rollout at “warp speed” — possibly by the end of the year — but the bar set for an effective, long-lasting vaccine is far too low and may prove dangerous, according to Marc Hellerstein of the University of California, Berkeley.
Loading Class list ...